Stereotaxis, Inc. (STXS)
USD 2.02
(0.0%)
USD 2.02
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 36.69 Million USD | -1.47% |
| 2022 | 37.24 Million USD | 3.12% |
| 2021 | 36.12 Million USD | 40.66% |
| 2020 | 25.67 Million USD | -6.93% |
| 2019 | 27.59 Million USD | 5.77% |
| 2018 | 26.08 Million USD | -0.85% |
| 2017 | 26.3 Million USD | -15.3% |
| 2016 | 31.06 Million USD | -4.86% |
| 2015 | 32.64 Million USD | 1.47% |
| 2014 | 32.17 Million USD | -10.31% |
| 2013 | 35.87 Million USD | -15.42% |
| 2012 | 42.4 Million USD | -30.97% |
| 2011 | 61.43 Million USD | 6.94% |
| 2010 | 57.44 Million USD | -0.9% |
| 2009 | 57.96 Million USD | -13.75% |
| 2008 | 67.2 Million USD | -8.18% |
| 2007 | 73.19 Million USD | 20.05% |
| 2006 | 60.97 Million USD | 18.83% |
| 2005 | 51.3 Million USD | 43.65% |
| 2004 | 35.71 Million USD | 43.37% |
| 2003 | 24.91 Million USD | 15.87% |
| 2002 | 21.5 Million USD | 55.46% |
| 2001 | 13.83 Million USD | 27.08% |
| 2000 | 10.88 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 8.71 Million USD | 8.33% |
| 2024 Q2 | 9.33 Million USD | 7.14% |
| 2023 FY | 36.69 Million USD | -1.47% |
| 2023 Q2 | 9.46 Million USD | -0.33% |
| 2023 Q1 | 9.49 Million USD | 8.33% |
| 2023 Q3 | 9.69 Million USD | 2.47% |
| 2023 Q4 | 8.04 Million USD | -17.08% |
| 2022 Q3 | 9.61 Million USD | -2.34% |
| 2022 FY | 37.24 Million USD | 3.12% |
| 2022 Q1 | 9.01 Million USD | -3.08% |
| 2022 Q2 | 9.84 Million USD | 9.28% |
| 2022 Q4 | 8.76 Million USD | -8.88% |
| 2021 Q4 | 9.29 Million USD | -0.59% |
| 2021 Q1 | 7.54 Million USD | 17.9% |
| 2021 FY | 36.12 Million USD | 40.66% |
| 2021 Q3 | 9.35 Million USD | -5.73% |
| 2021 Q2 | 9.92 Million USD | 31.53% |
| 2020 Q2 | 6.18 Million USD | -9.85% |
| 2020 Q1 | 6.85 Million USD | 8.26% |
| 2020 Q3 | 6.24 Million USD | 0.96% |
| 2020 Q4 | 6.39 Million USD | 2.52% |
| 2020 FY | 25.67 Million USD | -6.93% |
| 2019 FY | 27.59 Million USD | 5.77% |
| 2019 Q2 | 7.11 Million USD | -8.1% |
| 2019 Q3 | 6.41 Million USD | -9.83% |
| 2019 Q4 | 6.33 Million USD | -1.2% |
| 2019 Q1 | 7.73 Million USD | 20.41% |
| 2018 Q3 | 6.03 Million USD | -11.09% |
| 2018 FY | 26.08 Million USD | -0.85% |
| 2018 Q4 | 6.42 Million USD | 6.46% |
| 2018 Q1 | 6.83 Million USD | 15.26% |
| 2018 Q2 | 6.78 Million USD | -0.71% |
| 2017 Q2 | 6.69 Million USD | -12.12% |
| 2017 Q1 | 7.62 Million USD | 2.55% |
| 2017 FY | 26.3 Million USD | -15.3% |
| 2017 Q4 | 5.93 Million USD | -2.03% |
| 2017 Q3 | 6.05 Million USD | -9.63% |
| 2016 Q4 | 7.43 Million USD | 2.49% |
| 2016 FY | 31.06 Million USD | -4.86% |
| 2016 Q1 | 7.95 Million USD | -2.44% |
| 2016 Q2 | 8.41 Million USD | 5.85% |
| 2016 Q3 | 7.25 Million USD | -13.84% |
| 2015 Q3 | 7.73 Million USD | -8.38% |
| 2015 FY | 32.64 Million USD | 1.47% |
| 2015 Q4 | 8.15 Million USD | 5.4% |
| 2015 Q2 | 8.44 Million USD | 1.55% |
| 2015 Q1 | 8.31 Million USD | 16.13% |
| 2014 FY | 32.17 Million USD | -10.31% |
| 2014 Q3 | 7.69 Million USD | -7.86% |
| 2014 Q1 | 8.96 Million USD | 3.58% |
| 2014 Q2 | 8.35 Million USD | -6.83% |
| 2014 Q4 | 7.15 Million USD | -6.96% |
| 2013 Q2 | 9.01 Million USD | -8.09% |
| 2013 Q1 | 9.8 Million USD | 11.3% |
| 2013 Q4 | 8.65 Million USD | 3.15% |
| 2013 FY | 35.87 Million USD | -15.42% |
| 2013 Q3 | 8.39 Million USD | -6.93% |
| 2012 Q2 | 11.88 Million USD | -6.36% |
| 2012 Q3 | 9 Million USD | -24.22% |
| 2012 Q4 | 8.81 Million USD | -2.18% |
| 2012 Q1 | 12.69 Million USD | -1.38% |
| 2012 FY | 42.4 Million USD | -30.97% |
| 2011 FY | 61.43 Million USD | 6.94% |
| 2011 Q1 | 15.98 Million USD | 13.34% |
| 2011 Q2 | 17.63 Million USD | 10.31% |
| 2011 Q3 | 14.94 Million USD | -15.24% |
| 2011 Q4 | 12.87 Million USD | -13.84% |
| 2010 Q4 | 14.1 Million USD | 3.62% |
| 2010 Q3 | 13.6 Million USD | -13.76% |
| 2010 Q2 | 15.78 Million USD | 13.08% |
| 2010 Q1 | 13.95 Million USD | -8.71% |
| 2010 FY | 57.44 Million USD | -0.9% |
| 2009 Q4 | 15.28 Million USD | 15.39% |
| 2009 Q1 | 14.8 Million USD | 1.46% |
| 2009 Q2 | 14.63 Million USD | -1.15% |
| 2009 FY | 57.96 Million USD | -13.75% |
| 2009 Q3 | 13.24 Million USD | -9.46% |
| 2008 Q2 | 18.66 Million USD | 4.63% |
| 2008 FY | 67.2 Million USD | -8.18% |
| 2008 Q1 | 17.83 Million USD | -5.48% |
| 2008 Q4 | 14.58 Million USD | -9.46% |
| 2008 Q3 | 16.11 Million USD | -13.68% |
| 2007 Q1 | 16.71 Million USD | 13.69% |
| 2007 Q4 | 18.87 Million USD | 1.05% |
| 2007 Q3 | 18.67 Million USD | -1.32% |
| 2007 Q2 | 18.92 Million USD | 13.21% |
| 2007 FY | 73.19 Million USD | 20.05% |
| 2006 Q2 | 15.54 Million USD | 2.96% |
| 2006 FY | 60.97 Million USD | 18.83% |
| 2006 Q4 | 14.7 Million USD | -6.34% |
| 2006 Q3 | 15.7 Million USD | 1.02% |
| 2006 Q1 | 15.09 Million USD | 10.81% |
| 2005 Q4 | 13.62 Million USD | 5.02% |
| 2005 FY | 51.3 Million USD | 43.65% |
| 2005 Q2 | 14.58 Million USD | 43.93% |
| 2005 Q1 | 10.13 Million USD | 11.68% |
| 2005 Q3 | 12.97 Million USD | -11.06% |
| 2004 FY | 35.71 Million USD | 43.37% |
| 2004 Q2 | -7.12 Million USD | 0.0% |
| 2004 Q3 | 8.37 Million USD | 217.47% |
| 2004 Q4 | 9.07 Million USD | 8.33% |
| 2003 Q2 | 2.71 Million USD | 0.0% |
| 2003 FY | 24.91 Million USD | 15.87% |
| 2002 FY | 21.5 Million USD | 55.46% |
| 2001 FY | 13.83 Million USD | 27.08% |
| 2000 FY | 10.88 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| InfuSystem Holdings, Inc. | 59.02 Million USD | 37.82% |
| Milestone Scientific Inc. | 13.83 Million USD | -165.22% |
| Retractable Technologies, Inc. | 20.59 Million USD | -78.185% |